Literature DB >> 20132719

Systematic risks from chloramphenicol eye drops.

C I Phillips.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20132719      PMCID: PMC2814277          DOI: 10.3399/bjgp10X483300

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  7 in total

1.  Relative impact of clinical evidence and over-the-counter prescribing on topical antibiotic use for acute infective conjunctivitis.

Authors:  Helen Davis; David Mant; Caroline Scott; Daniel Lasserson; Peter W Rose
Journal:  Br J Gen Pract       Date:  2009-12       Impact factor: 5.386

2.  Article removed after US complains it could help terrorists.

Authors:  Owen Dyer
Journal:  BMJ       Date:  2005-06-18

3.  Managing conjunctivitis in general practice: research into management strategies for acute infective conjunctivitis.

Authors:  Scott J Robbie; Kashif Qureshi; Shahram Kashani; Muhammad A Qureshi
Journal:  BMJ       Date:  2006-08-26

4.  Risk of systemic toxicity from topical ophthalmic chloramphenicol.

Authors:  C I Phillips
Journal:  Scott Med J       Date:  2008-08       Impact factor: 0.729

5.  Topical administration of chloramphenicol can induce acute hepatitis.

Authors:  B Doshi; S Sarkar
Journal:  BMJ       Date:  2009-06-12

6.  Chloramphenicol treatment for acute infective conjunctivitis in children in primary care: a randomised double-blind placebo-controlled trial.

Authors:  Peter W Rose; Anthony Harnden; Angela B Brueggemann; Rafael Perera; Aziz Sheikh; Derrick Crook; David Mant
Journal:  Lancet       Date:  2005 Jul 2-8       Impact factor: 79.321

7.  A randomised controlled trial of management strategies for acute infective conjunctivitis in general practice.

Authors:  Hazel A Everitt; Paul S Little; Peter W F Smith
Journal:  BMJ       Date:  2006-07-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.